Myotonic dystrophy type 1 and PGD: Ovarian stimulation response and correlation analysis between ovarian reserve and genotype

Reproductive BioMedicine Online

Volumn 20, Issue 5, 2010, Pages 610-618

  Dechanet, C ^a   Castelli, C ^b   Reyftmann, L ^a   Coubes, C ^a   Hamamah, S ^a   Hedon, B ^a   Dechaud, H ^a   Anahory, T ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Genotype; Myotonic dystrophy type 1; Ovarian reserve; Ovarian stimulation; PGD

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ENDO; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN; UNCLASSIFIED DRUG;

ADRENOLEUKODYSTROPHY; AGE; ANTRAL FOLLICLE COUNT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DUCHENNE MUSCULAR DYSTROPHY; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; GENETIC SCREENING; GENOTYPE; HEMOPHILIA A; HEMOPHILIA B; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; LUTEINIZING HORMONE BLOOD LEVEL; LYMPHOPROLIFERATIVE DISEASE; MENTAL DEFICIENCY; MYOTONIC DYSTROPHY; OOCYTE; OVARIAN RESERVE; OVARIAN STIMULATION; OVARY FOLLICLE; OVARY FOLLICLE CELL; PELIZAEUS MERZBACHER DISEASE; PHARMACOLOGICAL STIMULATION; PREGNANCY RATE; PREIMPLANTATION GENETIC DIAGNOSIS; RETINITIS PIGMENTOSA; RETROSPECTIVE STUDY; X CHROMOSOME LINKED DISORDER; X CHROMOSOME RECESSIVE DISORDER;

EID: 77952883757     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2010.02.003     Document Type: Article

References (51)

1. Anvret, M., Ahlberg, G., Grandell, U., Hedberg, B., Johnson, K., Edstrom, L., 1993. Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophy. Hum. Mol. Genet. 2, 1397-1400.
2. Broekmans, F.J., Kwee, J., Hendriks, D.J., Mol, B.W., Lambalk, C.B., 2006. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum. Reprod. Update 12, 685-718.
3. Brook, J.D., McCurrach, M.E., Harley, H.G., et al., 1992. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68, 799-808.
4. Buxton, J., Shelbourne, P., Davies, J., et al., 1992. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547-548.
5. Cho, D.H., Tapscott, S.J., 2007. Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim. Biophys. Acta 1772, 195-204.
6. Clarke, N.R., Kelion, A.D., Nixon, J., Hilton-Jones, D., Forfar, J.C., 2001. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy? Heart 86, 411-416.
7. Dean, N.L., Tan, S.L., Ao, A., 2006. Instability in the transmission of the myotonic dystrophy CTG repeat in human oocytes and preimplantation embryos. Fertil. Steril. 86, 98-105.
8. De Rademaeker, M., Verpoest, W., De Rycke, M., et al., 2009. Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child. Eur. J. Hum. Genet., 15.
9. De Temmerman, N., Seneca, S., Van Steirteghem, A., et al., 2008. CTG repeat instability in a human embryonic stem cell line carrying the myotonic dystrophy type 1 mutation. Mol. Hum. Reprod. 14, 405-412.
10. De Temmerman, N., Sermon, K., Seneca, S., et al., 2004. Intergenerational instability of the expanded CTG repeat in the DMPK gene: studies in human gametes and preimplantation embryos. Am. J. Hum. Genet. 75, 325-329.
11. Feyereisen, E., Amar, A., Kerbrat, V., et al., 2006. Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation? Hum. Reprod. 21, 175-182. (Pubitemid 41794308)
12. n trinucleotide repeats. Am. J. Med. Genet. 65, 342-347.
13. Giordano, M., De Angelis, M.S., Cantello, R., Abdirisak, N.A., Mutani, R., Momigliano Richiardi, P., 1995. Problems arising in correlating clinical and molecular data in myotonic dystrophy. Clin. Genet. 47, 302-304.
14. Girardet, A., Hamamah, S., Anahory, T., et al., 2003. First preimplantation genetic diagnosis of hereditary retinoblastoma using informative microsatellite markers. Mol. Hum. Reprod. 9, 111-116.
15. Gleicher, N., Weghofer, A., Barad, D.H., 2009. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil. Steril. 91, 1700-1706.
16. Harley, H.G., Rundle, S.A., MacMillan, J.C., et al., 1993. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am. J. Hum. Genet. 52, 1164-1174.
17. Harley, H.G., Rundle, S.A., Reardon, W., et al., 1992. Unstable DNA sequence in myotonic dystrophy. Lancet 339, 1125-1128.
18. Harper, P., 1997. Myotonic Dystrophy. Emery and Rimoin's Principles and Practice of Medical Genetics. Churchill Livingstone, New York, pp. 2425-2443.
19. Harper, J.C., de Die-Smulders, C., Goossens, V., et al., 2008. ESHRE PGD consortium data collection VII: cycles from January to December 2004 with pregnancy follow-up to October 2005. Hum. Reprod. 31, 1-15.
20. Hortas, M.L., Castilla, J.A., Gil, M.T., et al., 2000. Reased sperm function of patients with myotonic muscular dystrophy. Hum. Reprod. 15, 445-448.
21. n repeat variation and selection against extreme expansion in sperm. Am. J. Hum. Genet. 54, 575-585.
22. Jayaprakasan, K., Campbell, B., Hopkisson, J., Johnson, I., Raine-Fenning, N., 2008. A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil. Steril., 29.
23. Kakourou, G., Dhanjal, S., Mamas, T., et al., 2008. Preimplantation genetic diagnosis for myotonic dystrophy type 1 in the UK. Neuromuscul. Disord. 18, 131-136.
24. Kwee, J., Elting, M.E., Schats, R., McDonnell, J., Lambalk, C.B., 2007. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization. Reprod. Biol. Endocrinol. 5, 9.
25. Lavedan, C., Hofmann-Radvanyi, H., Shelbourne, P., et al., 1993. Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am. J. Hum. Genet. 52, 875-883.
26. Liebars, I., Sermon, K., Staessen, C., Joris, H., Lissens, W., Van Assche, E., Nagy, P., Bonduelle, M., Vandervorst, M., Devroey, P., 1998. Clinical experience with preimplantation genetic diagnosis and intracytoplasmic sperm injection. Hum. Reprod. 13, 186-195.
27. Macas, E., Matyas, G., Reuge, P., Berger, W., Imthurn, B., 2009. Polar body biopsy for Curschmann-Steinert disease and successful pregnancy following embryo vitrification. Reprod. Biomed. Online 18, 815-820.
28. Mahadevan, M., Tsilfidis, C., Sabourin, L., et al., 1992. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255, 1253-1255.
29. Marchini, C., Lonigro, R., Verriello, L., Pellizzari, L., Bergonzi, P., Damante, G., 2000. Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy. Clin. Genet. 57, 74-82.
30. Martorell, L., Monckton, D.G., Gamez, J., Baiget, M., 2000. Complex patterns of male germline instability and somatic mosaicism in myotonic dystrophy type 1. Eur. J. Hum. Genet. 8, 423-430.
31. Mastrogiacomo, I., Bonanni, G., Menegazzo, E., et al., 1996. Clinical and hormonal aspects of male hypogonadism in myotonic dystrophy. Ital. J. Neurol. Sci. 17, 59-65.
32. n triplet mutation. J. Endocrinol. Invest. 17, 381-383.
33. Melacini, P., Villanova, C., Menegazzo, E., et al., 1995. Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy. J. Am. Coll. Cardiol. 25, 239-245.
34. Monckton, D.G., Wong, L.J., Ashizawa, T., Caskey, C.T., 1995. Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum. Mol. Genet. 4, 1-8.
35. Morrone, A., Pegoraro, E., Angelini, C., Zammarchi, E., Marconi, G., Hoffman, E.P., 1997. RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. J. Clin. Invest. 99, 1691-1698.
36. Muttukrishna, S., McGarrigle, H., Wakim, H., Khadum, I., Ranieri, D.M., Serhal, P., 2005. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 112, 1384-1390.
37. Nardo, G., Gelbaya, A., Wilkinson, H., et al., 2009. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil. Steril. 92, 1586-1593.
38. n > 700 repeats. Neuromuscul. Disord. 5, 157-159.
39. n triplet mutation and phenotype manifestations in myotonic dystrophy patients. Biochem. Med. Metab. Biol. 50, 85-92.
40. Perseghin, G., Caumo, A., Arcelloni, C., et al., 2003. Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy. Diabetes Care 26, 2112-2118. (Pubitemid 41184261)
41. Rohr, J., Allen, E.G., Charen, K., et al., 2008. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum. Reprod. 23, 1220-1225.
42. Sahu, B., Ozturk, O., Deo, N., Fordham, K., Ranierri, M., Serhal, P., 2008. Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I. J. Assist. Reprod. Genet. 25, 1-5.
43. Sarkar, P.S., Paul, S., Han, J., Reddy, S., 2004. Six5 is required for spermatogenic cell survival and spermiogenesis. Hum. Mol. Genet. 13, 1421-1431.
44. Savkur, R.S., Philips, A.V., Cooper, T.A., 2001. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29, 40-47.
45. Savouret, C., Garcia-Cordier, C., Megret, J., te Riele, H., Junien, C., Gourdon, G., 2004. MSH2-dependent germinal CTG repeat expansions are produced continuously in spermatogonia from DM1 transgenic mice. Mol. Cell. Biol. 24, 629-637.
46. Sermon, K., Lissens, W., Joris, H., et al., 1997. Clinical application of preimplantation diagnosis for myotonic dystrophy. Prenat. Diagn. 17, 925-932.
47. Verpoest, W., De Rademaeker, M., Sermon, K., et al., 2008. Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis. Hum. Reprod. 23, 1654-1660.
48. Willis, D., Mason, H., Gilling-Smith, C., Franks, S., 1996. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J. Clin. Endocrinol. Metab. 81, 302-309.
49. Wittenberger, M.D., Hagerman, R.J., Sherman, S.L., et al., 2007. The FMR1 premutation and reproduction. Fertil. Steril. 87, 456-465.
50. Wohrle, D., Kennerknecht, I., Wolf, M., Enders, H., Schwemmle, S., Steinbach, P., 1995. Heterogeneity of DM kinase repeat expansion in different fetal tissues and further expansion during cell proliferation in vitro: evidence for a casual involvement of methyl-directed DNA mismatch repair in triplet repeat stability. Hum. Mol. Genet. 4, 1147-1153.
51. Wong, L.J., Ashizawa, T., Monckton, D.G., Caskey, C.T., Richards, C.S., 1995. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am. J. Hum. Genet. 56, 114-122.